TheiDerm is the world's first hybrid plasma-microwave therapeutic platform, delivering continuous atmospheric plasma and microwave energy simultaneously without harmful ozone, electrical arcing, or thermal tissue damage. Its non-invasive approach is inherently safer than invasive alternatives while increasing skin permeability to boost absorption of therapeutic actives. Protected by two U.S. patents, its proprietary plasma discharge architecture is fundamentally different from conventional plasma devices that force a trade-off between safety and effectiveness. TheiDerm combines non-thermal atmospheric plasma with microwave energy to promote skin regeneration, aesthetic treatment, inflammation control, and wound and scar management, non-invasively and with no downtime. Cleared as a Class II medical device by Korea's MFDS (K-FDA), with a U.S. FDA 510(k) submission in progress, and validated in six peer-reviewed studies in human and veterinary applications, TheiDerm is proven safe and effective. This unique platform expands access to safer, gentle therapy and sets a new standard for plasma medicine.